Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8123608rdf:typepubmed:Citationlld:pubmed
pubmed-article:8123608lifeskim:mentionsumls-concept:C0042153lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C0007004lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C0016745lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C0043369lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C1507227lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:8123608lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:8123608pubmed:issue6lld:pubmed
pubmed-article:8123608pubmed:dateCreated1994-4-11lld:pubmed
pubmed-article:8123608pubmed:abstractTextThe utilization of a 4:2:1 mixture of glucose, fructose, and xylitol (GFX) was studied by indirect calorimetry in patients undergoing abdominal surgery. Sixteen patients undergoing gastrectomy under general anesthesia received GFX intravenously at 0.25 g/kg h-1 during surgery. VO2, VCO2, and RQ were measured continuously for 150 min using an Engström metabolic computer, and urea nitrogen excretion was determined at 30-min intervals during surgery. Blood levels of glucose, fructose, and xylitol plateaued after 1 h. The RQ decreased over the first 90 min from 0.84 +/- 0.06 to 0.75 +/- 0.05 and then gradually increased to 0.79 +/- 0.04 at 150 min. VO2 did not change significantly over the 150-min period. From the RQ, VO2, and nitrogen excretion data, carbohydrate oxidation was estimated. The amount of carbohydrate oxidized was 9.7 +/- 6.9 g during the first 30-min period, 3.5 +/- 5.2 g during the 60 to 90-min period, and 7.5 +/- 4.5 g in the 120 to 150-min study period. Simultaneously, lipid oxidation increased. These observations suggest that the GFX solution is adequately metabolized during surgery and therefore may be a suitable energy source for patients.lld:pubmed
pubmed-article:8123608pubmed:languageenglld:pubmed
pubmed-article:8123608pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8123608pubmed:citationSubsetIMlld:pubmed
pubmed-article:8123608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8123608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8123608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8123608pubmed:statusMEDLINElld:pubmed
pubmed-article:8123608pubmed:issn0894-1939lld:pubmed
pubmed-article:8123608pubmed:authorpubmed-author:KanekoMMlld:pubmed
pubmed-article:8123608pubmed:authorpubmed-author:KawachiSSlld:pubmed
pubmed-article:8123608pubmed:authorpubmed-author:YugeOOlld:pubmed
pubmed-article:8123608pubmed:authorpubmed-author:SumiyoshiNNlld:pubmed
pubmed-article:8123608pubmed:authorpubmed-author:YamamoriYYlld:pubmed
pubmed-article:8123608pubmed:issnTypePrintlld:pubmed
pubmed-article:8123608pubmed:volume6lld:pubmed
pubmed-article:8123608pubmed:ownerNLMlld:pubmed
pubmed-article:8123608pubmed:authorsCompleteYlld:pubmed
pubmed-article:8123608pubmed:pagination477-84lld:pubmed
pubmed-article:8123608pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:meshHeadingpubmed-meshheading:8123608-...lld:pubmed
pubmed-article:8123608pubmed:articleTitleUtilization of a glucose/fructose/xylitol carbohydrate solution during surgery.lld:pubmed
pubmed-article:8123608pubmed:affiliationDepartment of Anesthesia, Matsue Red Cross Hospital, Japan.lld:pubmed
pubmed-article:8123608pubmed:publicationTypeJournal Articlelld:pubmed